SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-23-020773
Filing Date
2023-06-09
Accepted
2023-06-09 17:33:25
Documents
9

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 424861
2 ex4-5.htm EX-4.5 556726
3 ex4-6.htm EX-4.6 578739
4 ex5-01.htm EX-5.01 27261
5 ex23-1.htm EX-23.1 4353
6 ex-107.htm EX-FILING FEES 12673
7 forms3_001.jpg GRAPHIC 3486
8 ex5-01_001.jpg GRAPHIC 4023
9 ex5-01_002.jpg GRAPHIC 13778
  Complete submission text file 0001493152-23-020773.txt   1635286
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272580 | Film No.: 231006490
SIC: 2834 Pharmaceutical Preparations